Naturligt forekommende oseltamivirresistens hos influenza A

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Naturligt forekommende oseltamivirresistens hos influenza A. / Madsen, Laura; Nielsen, Alex; Lundgren, Jens.

In: Ugeskrift for Laeger, Vol. 172, No. 32, 09.08.2010, p. 2165-7.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Madsen, L, Nielsen, A & Lundgren, J 2010, 'Naturligt forekommende oseltamivirresistens hos influenza A', Ugeskrift for Laeger, vol. 172, no. 32, pp. 2165-7.

APA

Madsen, L., Nielsen, A., & Lundgren, J. (2010). Naturligt forekommende oseltamivirresistens hos influenza A. Ugeskrift for Laeger, 172(32), 2165-7.

Vancouver

Madsen L, Nielsen A, Lundgren J. Naturligt forekommende oseltamivirresistens hos influenza A. Ugeskrift for Laeger. 2010 Aug 9;172(32):2165-7.

Author

Madsen, Laura ; Nielsen, Alex ; Lundgren, Jens. / Naturligt forekommende oseltamivirresistens hos influenza A. In: Ugeskrift for Laeger. 2010 ; Vol. 172, No. 32. pp. 2165-7.

Bibtex

@article{4b913557494749038d72eee32daedce3,
title = "Naturligt forekommende oseltamivirresistens hos influenza A",
abstract = "During the last two influenza seasons, one of the predominant influenza A types (H1N1) has developed complete resistance to oseltamivir, the primary treatment option. The virus does, however, remain sensitive to zanamavir and amantadine. There is no unequivocal explanation for this slide in the development of resistance. The best prevention strategy remains vaccination of the general population to avoid immunity. Future antiviral treatment calls for knowledge about resistance to existing types of influenza and the availability of all three types of antiviral medication.",
author = "Laura Madsen and Alex Nielsen and Jens Lundgren",
year = "2010",
month = aug,
day = "9",
language = "Dansk",
volume = "172",
pages = "2165--7",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "32",

}

RIS

TY - JOUR

T1 - Naturligt forekommende oseltamivirresistens hos influenza A

AU - Madsen, Laura

AU - Nielsen, Alex

AU - Lundgren, Jens

PY - 2010/8/9

Y1 - 2010/8/9

N2 - During the last two influenza seasons, one of the predominant influenza A types (H1N1) has developed complete resistance to oseltamivir, the primary treatment option. The virus does, however, remain sensitive to zanamavir and amantadine. There is no unequivocal explanation for this slide in the development of resistance. The best prevention strategy remains vaccination of the general population to avoid immunity. Future antiviral treatment calls for knowledge about resistance to existing types of influenza and the availability of all three types of antiviral medication.

AB - During the last two influenza seasons, one of the predominant influenza A types (H1N1) has developed complete resistance to oseltamivir, the primary treatment option. The virus does, however, remain sensitive to zanamavir and amantadine. There is no unequivocal explanation for this slide in the development of resistance. The best prevention strategy remains vaccination of the general population to avoid immunity. Future antiviral treatment calls for knowledge about resistance to existing types of influenza and the availability of all three types of antiviral medication.

M3 - Tidsskriftartikel

VL - 172

SP - 2165

EP - 2167

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 32

ER -

ID: 40212343